Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > News Out

<< Previous

Bullboard Posts

Next >>

Comment by stocksnbonds458on May 02, 2024 9:58pm

202 Views

Post# 36020856

RE:RE:RE:News Out

I think the best case scenario is to have the FDA's pre-btd questions answered and submitted by sometime in Q3. The actual BTD submission would then likely be sometime Q4, with an answer from the FDA early 2025. The process is agonizingly long when you don't have deep pockets.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023